Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02768038
NCT02768038
Withdrawn
Not Applicable

The Role of Intestinal Microbiome ih the Pathogenesis and Course of Chronic Inflammatory Bowel Diseases

Turku University Hospital1 site in 1 country120 target enrollmentMay 1, 2016
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsColitis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colitis
Sponsor
Turku University Hospital
Enrollment
120
Locations
1
Primary Endpoint
Change of microbiome in chronic inflammatory bowel disease
Status
Withdrawn
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The aim is to examine the role of intestinal microbiota in the pathogenesis of chronic inflammatory bowel diseases (IBD)

Detailed Description

IBD patients to whom colonoscopy is performed will be recruited. Mucosal specimens from large intestine and terminal ileum will be collected as well as stool specimens. The microbiota will be analyzed at the microbiology laboratory and the results will be correlated with endoscopical, laboratory and histopathological findings.

Registry
clinicaltrials.gov
Start Date
May 1, 2016
End Date
December 1, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •patient refusal to participate

Outcomes

Primary Outcomes

Change of microbiome in chronic inflammatory bowel disease

Time Frame: 5 yrs

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Correlation Between Intestinal Microbiota, Inflamatory Biomarkers, Intestinal Morphology, Hepatic Fibrosis Degree and Vascular Reactivity.Microbial Colonization
NCT03178006Rio de Janeiro State University46
Recruiting
Not Applicable
The role of gut microbiota and chronic inflammation as drivers of cardiovascular disease - Nijmegen Biomedical Study - Non Invasive markers of Atherosclerosis 3
NL-OMON38378niversitair Medisch Centrum Sint Radboud500
Completed
Not Applicable
Gastrointestinal Microbiome Influence on the Development of Bronchopulmonary DysplasiaBronchopulmonary Dysplasia
NCT03229967University of Tennessee197
Completed
Not Applicable
The role of the intestinal microbiome in enteric and systemic vaccine immune responsesvaccin immunogeniciteitimmunityrotavirus vaccine1001796610047438
NL-OMON44814Academisch Medisch Centrum63
Unknown
Not Applicable
The Role of Gut Microbiome and Chronic Inflammation in Young-onset Colorectal CancerColorectal Cancer
NCT04011969Fakultas Kedokteran Universitas Indonesia150